Key Performance Indicators to Measure Post Market Surveillance Effectiveness for Device Portfolios Post market surveillance (PMS) is an essential aspect of medical device regulation aimed at ensuring that devices remain safe and effective throughout their lifecycle. A robust PMS system enables manufacturers to respond promptly to safety signals, enhance product quality, and ensure compliance with regulatory requirements such as those specified in 21 CFR 803. In this guide, we will outline key performance indicators (KPIs) that can be employed to assess the effectiveness of post market surveillance activities for medical device portfolios. Understanding Post Market Surveillance and Its Regulatory Importance…

Auditor and inspector focus areas when reviewing PMS and MDR systems Auditor and inspector focus areas when reviewing PMS and MDR systems Understanding the Importance of Post-Market Surveillance (PMS) and Medical Device Reporting (MDR) Post-Market Surveillance (PMS) is a crucial component in the lifecycle of medical devices and is defined under the regulatory framework set forth by the FDA. Its primary objective is to collect and analyze information about the performance of medical devices after they have been marketed. It provides a mechanism for identifying safety signals and ensuring long-term safety and efficacy of devices in use. Regulatory, quality, clinical,…

Preparing Communications to Clinicians, Distributors and Patients During Recalls Effective communication during the recall of medical devices is critical for ensuring safety and compliance with regulatory requirements. Medical device manufacturers are accountable for maintaining effective post-market surveillance, promptly managing MDR corrections and removals, and effectively communicating critical information to clinicians, distributors, and patients. Understanding the regulatory framework that governs these communications is essential for regulatory, quality, clinical, and RA/QA professionals working with medical devices and combination products. Understanding the Regulatory Framework for Post-Market Surveillance The U.S. Food and Drug Administration (FDA) requires that medical device manufacturers establish and maintain comprehensive…

Documentation Expectations for Corrections, Removals, and Recall Decisions Medical devices are subject to rigorous regulatory oversight meant to ensure their safety and efficacy. An essential part of this oversight involves the documentation expectations surrounding corrections, removals, and recall decisions that arise in the post-market phase of a medical device’s lifecycle. Understanding these expectations is critical not only for compliance with 21 CFR 803 but also for aligning with global vigilance requirements and ensuring patient safety. This guide offers a step-by-step tutorial for regulatory, quality, clinical, and RA/QA professionals. Understanding Post-Market Surveillance and MDR Reporting Post-market surveillance is a crucial aspect…

Digital Tools and Dashboards for Trending Device Complaints and Incidents Introduction to Post-Market Surveillance The post-market surveillance (PMS) of medical devices is a critical aspect of regulatory compliance and safety management. It pertains to the ongoing monitoring of devices after they have been approved for market use. With advancements in technology, regulatory bodies like the US FDA have emphasized the need for robust systems to constantly evaluate device performance, monitor adverse events, and detect trends related to complaints and incidents. This tutorial aims to provide regulatory and quality professionals with a comprehensive understanding of digital tools and dashboards that can…

Interplay between FDA premarket cybersecurity guidance and postmarket controls Interplay between FDA premarket cybersecurity guidance and postmarket controls The digital landscape has increasingly influenced the medical device industry, particularly with the rise of Software in Medical Devices (SiMD). As medical technologies evolve, the US FDA has established specific frameworks intended to ensure both safety and effectiveness, particularly in the context of cybersecurity. This article will provide a step-by-step guide on understanding the regulatory interplay between FDA premarket cybersecurity guidance and postmarket controls, particularly for professionals involved with regulatory compliance, quality assurance, and clinical evaluations. Understanding the Landscape of SiMD and…

Post Market Cybersecurity Monitoring and Patch Management for Devices Cybersecurity in medical devices is a growing concern that affects patient safety and the healthcare ecosystem at large. The U.S. Food and Drug Administration (FDA) has developed specific guidelines and regulations that outline expectations for manufacturers regarding the cybersecurity of software in medical devices (SiMD). This article serves as a comprehensive regulatory tutorial designed for regulatory, quality, clinical, and RA/QA professionals engaged with medical devices and combination products. It will detail the necessary steps for post-market cybersecurity monitoring and patch management. Understanding the Regulatory Framework for Cybersecurity in Medical Devices The…

SBOM Requirements and Third Party Component Management for SiMD In the evolving landscape of medical device regulation, the integration of software in medical devices (SiMD) has led to heightened scrutiny regarding cybersecurity and the use of third-party components. The FDA, alongside international standards such as IEC 62304, outlines critical requirements for developers and manufacturers of SiMD. This tutorial aims to provide a comprehensive, step-by-step guide for regulatory, quality, clinical, and RA/QA professionals navigating the complexities of SBOM (Software Bill of Materials) requirements and component management. Through alignment with FDA expectations, this guide positions you to ensure regulatory compliance effectively. Understanding…

Software Validation, Unit Testing and Integration Testing Under QSR In the complex landscape of medical device regulation, ensuring the functionality and safety of software in medical devices (SiMD) is critical. The U.S. Food and Drug Administration (FDA) has established rigorous guidelines that mandate specific verifications, including software validation, unit testing, and integration testing, in compliance with the Quality System Regulations (QSR). This article will serve as a regulatory tutorial for professionals involved in the development and oversight of SiMD, focusing on the crucial aspects required to demonstrate compliance with FDA regulations. Understanding the Landscape of Software in Medical Devices (SiMD)…

Coordinating Software, Cybersecurity, and Usability Files in Device Dossiers As the regulatory environment surrounding medical devices continues to evolve, the integration of software in medical devices (SiMD) has become increasingly prevalent. With this evolution comes the need to ensure that regulatory, quality, clinical, and RA/QA professionals fully understand the requirements mandated by the FDA and other global regulatory agencies. This comprehensive tutorial will provide a step-by-step guide on how to effectively coordinate software, cybersecurity, and usability files in device dossiers while navigating the complexities associated with the US FDA regulations and guidance, with occasional references to EU and UK standards…